Why it matters
A validated, intervention-responsive healthspan score could materially change trial design, product claims, reimbursement evidence, and how healthspan is measured outside decades-long studies.
Decision implication
Track the construction, validation, endpoint properties, and public availability of the PROSPR-IC score.
Who or what is affected
- ARPA-H
- Stanford
- researchers
- digital-health developers
- regulators
Evidence and sources
Decision priority: Watch
Source authority: Primary/authoritative · official federal award description
Evidence design: Program record
Applicability: Direct
Confidence for the stated claim: High
Freshness: Current
P4L distinguishes the sourced record from interpretation. Program inclusion, participation, funding, proposal status, or a public listing does not by itself establish clinical effectiveness, endorsement, coverage, or scaled adoption unless the cited source specifically establishes it.
For this decision
Researchers · Innovators · Funders/investors · Policymakers · Clinicians
What P4L is watching next
- Score definition
- validation results
- intervention responsiveness
- regulatory acceptance.
Related proof records
- CLM-0013 — ARPA-H says the PROSPR THRIVE team will generate a PROSPR-IC healthspan score from harmonized existing datasets and test it in a one-year lifestyle intervention.
- CLM-0020 — A validated, intervention-responsive healthspan score could materially alter trial design, product claims, evidence generation, and reimbursement strategy.
Record provenance
- Last verified
- 2026-09-03
- Source date (award start)
- 2026-02-24
- Revision state
- Version 1.1 replaces execution-implying language with the prospective THRIVE award description, adds the no-validation/no-results boundary, and records the September 3, 2026 re-verification.
- Status
- Current ARPA-H award description · prospective work · no validation or results reported
- Freshness
- Current
- Version
- 1.1
- Stable ID
- SIG-2026-006